(KSTR) KraneShares SSE STAR Market - Overview
Etf: Semiconductors, Technology, China
| Risk 5d forecast | |
|---|---|
| Volatility | 33.7% |
| Relative Tail Risk | -14.0% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.34 |
| Alpha | 45.97 |
| Character TTM | |
|---|---|
| Beta | 0.541 |
| Beta Downside | 0.412 |
| Drawdowns 3y | |
|---|---|
| Max DD | 47.67% |
| CAGR/Max DD | 0.16 |
Description: KSTR KraneShares SSE STAR Market December 22, 2025
The KraneShares SSE STAR Market 50 Index ETF (KSTR) seeks to track the performance of the 50 largest free-float Chinese companies listed on the STAR Board, allocating at least 80% of net assets (plus any investment-purpose borrowings) to securities that replicate the index’s composition; as a non-diversified fund, it concentrates exposure in high-growth technology and biotech firms.
Key metrics as of the latest filing show an expense ratio of 0.65% and total assets under management of roughly $350 million, with the top sector weights being semiconductor equipment (~22%), software & services (~18%), and life-science equipment (~12%). Recent drivers include China’s “Made in China 2025” policy, which channels state subsidies toward domestic chip design and AI research, and the STAR Board’s relaxed IPO approval process that has accelerated capital raising for innovative firms. However, the ETF remains sensitive to regulatory shifts and US-China geopolitical risk, which can materially affect valuation multiples.
For a deeper, data-driven view of how KSTR fits into broader China-tech exposure, you may find ValueRay’s analytical dashboard useful.
What is the price of KSTR shares?
Over the past week, the price has changed by -3.38%, over one month by +2.73%, over three months by +5.29% and over the past year by +52.59%.
Is KSTR a buy, sell or hold?
What are the forecasts/targets for the KSTR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 22.3 | 9.7% |
KSTR Fundamental Data Overview February 04, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 89.7m USD (89.7m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 89.7m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 89.7m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 7.91% (E(89.7m)/V(89.7m) * Re(7.91%) + (debt-free company))
Discount Rate = 7.91% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Fair Price DCF = unknown (Cash Flow 0.0)